Parkinson's disease (PD), characterized by tremor, rigidity, postural instability, and bradykinesia, is the most common serious movement disorder in the world, affecting about 1% of adults older than 60 years 1 . The dopamine (DA) related oxidative stress was suggested to be the key event in the genesis of PD 2 . DA oxidation could produce reactive oxygen species (ROS) and reactive DA quinones 3 . The ROS could lead to comprehensive damage including proteins, lipids and nucleic acids in cells 4 . On the other hand, DA quinones are highly reactive and could covalently react with the cysteine residues of functional proteins and irreversibly inhibit their activity 5, 6 . The highly reactive DA-derived DA quinones rather than ROS have been suggested to play an important role in DA-induced toxicity related to PD pathogenesis [7] [8] [9] . Various studies have shown that DA-derived DA quinones could impair mitochondria contributing to dopaminergic neuron demise [10] [11] [12] .
Our previous study has also demonstrated that DA could induce irreversible proteasome inhibition via DA-derived quinones rather than via the ROS 13 .
To date, GSH has been implicated to be an important endogenous protective factor against the toxicity of DA 14, 15 . GSH could detoxify DA-related toxicity through conjugation with DAderived quinones, besides scavenging ROS 16, 17 . In the presence of GSH transferase, GSH could conjugate with DA-derived quinone to form 5-S-GSH-DA 16 . Furthermore GSH transferase could catalyze GSH conjugation with AM to form 4-S-GSH-5,6-dihydroxyindoline 17 . In our recent study using an improved tandem HPLC procedure coupled with ESI-MS, we found that GSH could actually react with AM to form various GSH conjugates without any enzymatic catalysis 18 . We have also shown in a separate study that DA-derived quinones are associated with cellular toxicity induced by mutant alpha-synuclein which is associated strongly with PD 19 .
Meanwhile, other investigators have reported that intrastriatal injection or administering of DA could significantly decrease GSH level in the brain of experimental animals as well as in cultured astroglial cells 20, 21 . In addition, postmortem studies have implicated the decrease of GSH level in the substantia nigra (SN) of the brain to be the early event for PD onset since there was an obvious decrease (~ 40 %) of GSH in the SN of early and advanced PD patients compared with the aged controls 22, 23 . Furthermore, when compared with aged controls, the highest level of GSH-DA conjugates were detected in the SN and putamen of postmortem PD patients 24 . Taken together, these observations inferred that the increased production of DA-derived quinones and consumption of GSH via conjugation between GSH and DA-derived quinones are vital events highly related to PD.
In this study, we report for the first time that GSH could rapidly conjugate with DA-derived quinones to form reactive or non-reactive GSH conjugates dependent on ambient reductive force and without any enzymatic catalysis. Based on our findings, two detrimental positive feedback loops leading to an imbalance between DA oxidation and GSH protective capacity are proposed to help us understand the chemical explanation underlying DA neuron degeneration. These detrimental feedback loops may act together in a vicious cycle aggravating GSH decrease in the brain, hence accounting for the onset of PD.
RESULTS
Our first set of analysis was to characterize the DA quinones derived from DA oxidation under different conditions as well as their conjugation with GSH. Our experimental data revealed that after DA was catalyzed by tyrosinase in the absence of GSH, AM could be detected and it surfaced as a peak in our HPLC A chromatogram (Fig. 1a) . However in the presence of GSH, the formation of AM was abrogated and new peaks corresponding to conjugates between GSH and DA-derived quinones emerged ( Fig. 1b -f; 1h) . We named these new peaks as p1, p2, p3
and p4 according to their retention time in the HPLC chromatogram: p1 = 2.30 min; p2 = 4.10 min; p3 = 4.65 min and p4 = 8.85 min (Fig. 1b -f) . In our previous study we had demonstrated that the compound corresponding to p1 was the polymerized form of GSH conjugatesresembled AM in its profile, which had light absorbance at 280, 375 and 475 nm wavelengths in the HPLC A chromatogram, as well as two light absorbance peaks at about 280 and 475 nm wavelengths in the light absorbance spectrometry; whereas p2 and p4 only had light absorbance at 280 nm wavelength (Fig. 1b -d, 1m ). Furthermore we found that the formation of GSH-DA quinone conjugates was GSH concentration dependent; with higher concentration of GSH leading to p2 and p4 formation, while lower concentration of GSH leading to p1 and p3 formation (Fig. 1) .
To better understand the nature of p1, p2, p3, and p4, we carefully analyzed their profiles of peak area changes in the chromatograms. Detailed changes in the area of the respective peaks after 1 mM DA had been catalyzed by 0 -200 unit tyrosinase for 20 min in the presence of 0.2 -8 mM GSH are illustrated in Figures 1g -l. We found that p1 and p3 emerged when the lowest GSH concentration (0.2 mM) was applied and reached their highest level when GSH concentration was about 0.5 mM, but began to decrease with further increase in GSH concentration (Fig. 1i, k) . Interestingly, p1 and p3 would completely disappear when GSH concentration was more than 1.5 mM (Fig. 1i, k) . On the other hand, p2 and p4 began to emerge when GSH concentration was more than 0.5 mM. The peak areas of p2 and p4 increased proportionally to GSH concentration till GSH concentration was about less than 1.5 mM, but decreased when GSH concentration was more than 1.5 mM (Fig. 1j, l) . The peak area of p4 was higher than that of p2, suggesting that the formation of p4 was more rapid than that of p2.
We also found that there was a curvilinear tendency in the change of DA peak areas after DA was catalyzed by 100 or 200 unit tyrosinase in the presence of different concentration of GSH (Fig. 1g) . We observed that the changes in peak areas of p3 (Fig. 1k) were closely synchronizing with that of DA peak areas changes (Fig. 1g) when GSH concentration was in the range of 0 -1.5 mM (200 unit tyrosinase) or 0 -1.0 mM (100 unit tyrosinase). The p3 and DA peak areas increased to a maximum when GSH concentration was 0.5 mM but decreased with GSH concentration further increase (0.5 -1.5 mM (200 unit tyrosinase) or 0.5 -1.0 mM (100 unit tyrosinase)) (Fig. 1g, k) . Since higher DA peak areas were indications of decreased tyrosinase activity, and they synchronized with the profile changes in p3, therefore p3 was implicated to cause tyrosinase inhibition when GSH concentration was in the range of 0.2 -1.0 or 1.5 mM. The DA peak areas decreased to the lowest level when GSH concentration was 1.0 mM (100 unit tyrosinase) or 1.5 mM (200 unit tyrosinase), and since in this concentration range p3 was absent, tyrosinase activity was not inhibited and hence DA oxidation could proceed (Fig. 1g) . However when GSH concentration was further increased to the range of 2 -8 mM, there was a corresponding gradual increase in DA peak areas (Fig. 1k ). Under such high concentration of GSH, the tyrosinase inhibition in the absence of p3 should be due to direct effect of GSH since in our previous studies we have demonstrated that GSH at high concentration could directly inhibit tyrosinase-catalyzed DA oxidation 19 . The inhibition of tyrosinase by GSH would lead to decreased production of DA-o-quiones and thereby decrease p2 and p4 formation accordingly, although high GSH concentration would favor p2 and p4 formation and disfavor p3 formation (Fig. 1g, j , k, l).
To further understand the nature of p1, p2, p3 and p4 we studied the conjugations between DA-quinones and GSH under different reaction time. We found that the formation of GSH-DA quinones conjugates were also reaction time dependent (Fig. 2) . We observed that after catalysis for 2 -10 min, only p2 and p4 emerged ( Fig. 2a -c) . However, after a longer incubation time (20 min or more time) p1, p3 and AM appeared ( Fig. 2d -f ). The p1 increased continually while p2, p3 and p4 would decline with time after reaching their highest levels. A logical explanation for these observations could be due to spontaneous polymerization of GSH conjugates in solutions over time. Detailed changes in the various peak areas with time in the presence of 0 -2 mM GSH are illustrated in Figure 2g -l. Interestingly, the speed of DA oxidation decelerated with time (especially in the presence of 0.5 mM GSH) (Fig. 2g) . After catalysis for 20 min in the presence of 0.5 mM GSH or for 240 min in the presence of 1 mM GSH, the peak areas of DA were significantly higher than those in the absence of GSH or in the presence of 2 mM GSH ( Fig.   2g ). These intriguing results inferred that tyrosinase was more significantly inhibited in the presence of 0.5 or 1 mM GSH than in the absence of GSH or in the presence of 2 mM GSH. As p3 only emerged when GSH concentrations were 0.5 and 1 mM but not in the presence of 2 mM GSH, these results implied again that p3 was actually inhibiting tyrosinase.
We next asked what would happen if we modify the ambient reductive forces in the solutions.
The results showed that the formation of GSH conjugates could be influenced by AA and NADPH ( Fig. 3) . The presence of 1 mM AA or 1 mM NADPH would significantly inhibit p1, p3
and AM formation but promote p2 and p4 formation ( Fig. 3a -c) . The decrease in AM and p3
peak areas was dependent on the AA and NADPH dosage (Fig. 3g , h, k, l). However, the influence of AA and NADPH concentrations on p4 peak areas ( Fig. 3i , m) and on DA peak areas ( Fig. 3f, j ) was observed to be bidirectional but opposite with one another. The p4 production rate was found to increase and then decrease with increasing AA or NADPH concentration after an 'optimal concentration' of the reductant was applied; whereas the DA peak areas decreased and then increased after the optimal reductant concentration was applied. We propose that the lower concentration of AA and NADPH could inhibit AM and p3 production, but promote p2 and p4 production, thereby facilitate tyrosinase catalysis and hence lead to decreased DA peak areas.
On the contrary, the higher concentration of AA and NADPH could directly inhibit tyrosinase catalysis as high concentration of GSH would, thereby decrease p4 formation and hence the corresponding increase in DA peak areas.
To further understand the chemical nature of conjugation reactions between DA quiones and GSH, the reaction solutions were first aerated with or without oxygen and nitrogen gas. In principle oxygen is able to receive protons and electrons and form water while nitrogen does not have such a property. We discovered that tyrosinase catalyzed oxidation of DA and formation of GSH conjugates could be influenced by these gases (Fig. 4) . We showed that when distilled water had been aerated with oxygen gas beforehand, p3 and AM peaks increased and DA peak decreased significantly while formation of p2 and p4 was abrogated (Fig. 4a, b, d ). However when distilled water had been aerated with nitrogen gas beforehand, the reverse situation emerged (Fig. 4c, d) . Obviously, oxygen facilitated AM and p3 formation while nitrogen facilitated p2 and p4 formation.
To identify the respective GSH conjugates, they were subjected to tandem HPLC plus ESI-MS analysis. The p2 and p4 were separated and collected from HPLC A procedure (Fig. 5a ).
The pH value of the collected solutions was adjusted to pH 8.0. The solutions were further incubated at 37 °C for 3 hrs. We found that after incubation under a basic pH condition, p2 and p4 would both aggregate and transform to p1 (Fig. 5b, e) . Alternatively the collected p2 and p4
from HPLC A procedure could be further purified through the HPLC B procedure (Fig. 5c, d ).
Peaks for p2 and p4 in HPLC B chromatogram were collected again and underwent ESI-MS analysis. We found that the molecular weight (MW) of p2 and p4 were both 458 (m/z = 459) ( Fig.   5f, g ). We therefore concluded that p2 and p4 are isomeric compounds and could form via conjugation between one GSH and one DA-derived quinone. However, p2 and p4 could not further conjugate with GSH in solutions (data not shown).
Similarly, we collected p3 and AM from HPLC A procedure (Fig. 6a) . Interestingly we found that p3 could automatically transform into a new GSH conjugate in solutions (Fig. 6b, e) .
This new GSH conjugate only had light absorbance at 280 nm wavelength and had retention time of about 9.30 min in HPLC A chromatogram (Fig. 6e) . We named the peak of this new GSH conjugate as p6. Almost all of p3 had transformed into p6 after 3 hr incubation (Fig. 6e) . We also demonstrated that incubation of p3 overnight at 37 °C under basic pH condition could lead to decrease of p6 peak areas and p1 formation, suggesting that p6 could also aggregate under basic conditions to form p1 (Fig. 6f) . We also found that p6 lost the ability to further react with GSH in solutions (data not shown). However we noticed that p3 was still reactive and could further conjugate with another GSH in solutions (Fig. 6c) . After incubating the collected p3 with 2 mM GSH for 3 hrs, a new peak emerged before p6 in HPLC A chromatogram, with a retention time of about 8.0 min and light absorbance at 280 nm wavelength (Fig. 6c) . We named this new peak p5.
Simultaneously, we revealed that AM collected from HPLC A could react with GSH to form a large peak and a tiny peak (Fig. 6d) . The large peak had retention time of about 9.90 min and light absorbance at 280 nm wavelength while the tiny peak was the same as p6 (Fig. 6d, g ). We named the new large peak p7. We later found that p7 also could not react with GSH (data not shown). Subsequently, p3, p5, p6 and p7 collected from HPLC A were further purified through HPLC B procedure and analyzed by ESI-MS (Fig. 6h -k) . Interestingly, the MW of p3, p6 and p7 were all found to be 454 (Fig. 6h, j, k) . Since p3, p6 and p7 all have the same molecular weight of 454, they are isomeric chemicals. The MW of p5 was about 759, corresponding nicely to two GSH conjugated with one DA-derived quinone (Fig. 6i) .
DISCUSSION
In our previous studies, we showed that our new HPLC procedures were suitable to separate DA It has been established that GSH could react with DA-o-quinone mainly at the 5 th position (C5) and secondarily at the 2 nd position (C2) to form more 5-S-GSH-DA (MW 458) and minor 2-S-GSH-DA (MW 458) 16, [25] [26] [27] . We therefore deduced that the identity of p2 should be 2-S-GSH-
DA and p4 should be 5-S-GSH-DA. The intermediate GSH conjugates for 2-S-GSH-DA and 5-S-GSH-DA should then be 2-S-GSH-DA-o-quinone (MW 456) and 5-S-GSH-DA-o-quinone (MW 456) respectively. The cyclization of 5-S-GSH-DA-o-quinone will form 7-S-GSH-AM (MW 454); whereas the cyclization of 2-S-GSH-DA-o-quinone will form 4-S-GSH-AM (MW 454). As the product of 5-S-GSH-DA-o-quinone is supposed to be more than that of 2-S-GSH-
DA-o-quinone, the product of cyclic 7-S-GSH-AM would be more than that of 4-S-GSH-AM.
We hence propose that p3 produced in a large amount should be 7-S-GSH-AM. However we have not observed peaks corresponding to 4-S-GSH-AM derived from 2-S-GSH-DA-o-quinone.
This might be due to the amount produced for 4-S-GSH-AM is much less than that of 7-S-GSH-AM. Furthermore since S-GSH-AM aggregates very fast in solution, the minor amount of 4-S-GSH-AM would have aggregated and disappeared before detection.
Our previous study has demonstrated that AM could conjugate with GSH in basic solutions (pH 7.8) to form 4,7-bi-S-GSH-5,6-dihydroxyindole (MW 759), 7-S-GSH-5,6-dihydroxyindole (MW 454), and 4-S-GSH-5,6-dihydroxyindole (MW 454) with retention time and MW corresponding to those of p5, p6 and p7 respectively in this study 18 . In the current study, we found that AM collected in acidic HPLC elution buffer (pH 4.75) could conjugate with GSH to mainly form p7, whereas the product of p6 was minor. We inferred that the identity of p5 should be 4,7-bi-S-GSH-5,6-dihydroxyindole; p6 should be 7-S-GSH-5,6-dihydroxyindole while p7
should be 4-S-GSH-5,6-dihydroxyindole. We also demonstrated in the current study that p3
could automatically transform into p6 (7-S-GSH-5,6-dihydroxyindole) which further supported the identity of p3 to be 7-S-GSH-AM. The previous findings that cyclized AM could undergo internal rearrangement to form 5,6-dihydroxyindole coincide with and support our current findings that cyclized 7-S-GSH-AM (p3) could rearrange to form 7-S-GSH-5,6-dihydroxyindole (p6) 28, 29 . With all the identities of the GSH conjugates and DA quinones put into a logical relationship, we can then make sense of the detailed process for GSH conjugates formation which is illustrated in Figure 7 .
The 7-S-GSH-AM is so reactive that it could conjugate with another GSH and even inhibit tyrosinase activity in solutions. Postmortem studies have shown that there were increased conjugates of cysteine or GSH with DA quinones implicating accelerated DA oxidation concomitant with obvious decreased (~ 40 %) GSH level in the substantia nigra (SN) of PD patients, which were not accompanied by a corresponding increase in glutathione disulfide (GSSG) [22] [23] [24] . Furthermore the decreased GSH level in SN was demonstrated to be the early events in the development of the disease 22, 23 . Our unpublished data showed that various iron species could trigger DA oxidation in solutions, which could not be inhibited by GSH but could be abrogated by iron chelator. The iron species have been established to be highly implicated for PD pathogenesis 30, 31 . Taken together, two detrimental positive feedback loops were proposed as depicted in Figure 8 . They involve accelerated DA oxidation, increased GSH consumption, decreased GSH detoxification efficiency and decreased GSH level, which collectively could contribute to PD (Fig. 8) .
The detrimental positive feedbacks could be triggered by pathological factors, such as iron accumulations, which will lead to an accelerated DA oxidation out of the control of GSH. The accelerated DA oxidation could produce DA quinones which could conjugate with GSH leading to irreversible depletion of GSH and decreased GSH level in the cells. The decreased GSH level will lead to reactive 7-S-GSH-AM formation which could further react with GSH and thus decrease GSH detoxification efficiency for DA quinones. This detrimental effect will lead to accelerated GSH consumption and aggravated decrease of GSH level in the cells. At the same time, the decreased GSH level will favor DA oxidation and contribute to increased oxidative stress and DA quinones production making a double-detriment to the cells. The ROS produced from DA oxidation will deplete endogenous reductants and thereby favor reactive 7-S-GSH-AM production. All these vicious cycle outcomes will lead to an imbalance between DA toxicity and GSH protective capacity and finally dopaminergic neuron degeneration. We believe that these mechanisms help us understand the chemical basis for PD onset and development.
If our proposed scheme is further validated through future researches, then therapies to elevate GSH level in cells; or the use of GSH substitutes with sulphydryl groups which could easily penetrate through the blood-brain-barrier; and the administration of exogenous reductants may very well function to hinder or break the vicious chemical feedbacks, and therefore benefit PD patients.
METHODS
Materials. Acetonitril, DA, EDTA, GSH, HEPES, tyrosinase (from mushroom), ascorbic acid (AA) and NADPH were all purchased from Sigma (U.S.A.).
The improved HPLC A procedure 17 . Our HPLC A procedure used two elution buffer systems (e), p4 collected were adjusted to pH about 8.0 and incubated 3 hrs at 37 °C and then analyzed by HPLC A procedure again.
(f and g), ESI-MS spectrum of GSH conjugates p2 (f) and p4 (g). conjugate with GSH leading to irreversible depletion of GSH and finally decreased GSH level in the brain. The decreased GSH level will lead to reactive GSH conjugates formation (7-S-GSH-AM) which could further react with GSH. This will lead to decreased GSH detoxification efficiency against DA quinones; accelerated GSH consumption and further aggravated decrease of GSH level (refer to the lower detrimental positive feedback loop). On the other hand, the decreased GSH level will favor DA oxidation and contribute to increased oxidative stress and DA quinones production (refer to the upper detrimental positive feedback loop). The ROS produced from DA oxidation will deplete endogenous reductants and favor reactive GSH conjugates formation. These effects will lead to an imbalance between DA toxicity and GSH protective capacity and finally account for dopaminergic neuron degeneration and PD onset. Strategies to elevate GSH level could directly stop the detrimental feedbacks. For example, GSH substitutes could be administered to conjugate with DA quinones and thus preserving GSH and help to elevate its level in the cells; or exogenous reductants could reduce the intermediate GSH conjugates to form non-reactive GSH conjugates and thereby help to break the vicious cycle due to the detrimental positive feedbacks.
